SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MELLONI, Elisabetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.918
AS - Asia 3.843
EU - Europa 2.395
SA - Sud America 566
Continente sconosciuto - Info sul continente non disponibili 195
AF - Africa 88
OC - Oceania 10
Totale 15.015
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.720
SG - Singapore 1.447
CN - Cina 889
IT - Italia 583
BR - Brasile 455
VN - Vietnam 448
DE - Germania 382
HK - Hong Kong 305
PL - Polonia 273
UA - Ucraina 260
GB - Regno Unito 245
TR - Turchia 194
BD - Bangladesh 130
FI - Finlandia 129
FR - Francia 123
CA - Canada 114
SE - Svezia 107
RU - Federazione Russa 101
JP - Giappone 85
IN - India 84
ID - Indonesia 73
NL - Olanda 50
MX - Messico 44
AR - Argentina 37
ZA - Sudafrica 36
ES - Italia 34
IQ - Iraq 29
PK - Pakistan 24
CO - Colombia 18
EC - Ecuador 18
BE - Belgio 17
SA - Arabia Saudita 17
LT - Lituania 16
AT - Austria 15
PH - Filippine 14
UZ - Uzbekistan 14
MY - Malesia 13
AE - Emirati Arabi Uniti 11
CL - Cile 11
MA - Marocco 11
VE - Venezuela 11
JM - Giamaica 10
AU - Australia 9
CZ - Repubblica Ceca 9
DZ - Algeria 8
TN - Tunisia 8
DO - Repubblica Dominicana 7
EG - Egitto 7
JO - Giordania 7
BO - Bolivia 6
CR - Costa Rica 6
IL - Israele 6
KE - Kenya 6
PY - Paraguay 6
RO - Romania 6
GR - Grecia 5
HN - Honduras 5
RS - Serbia 5
TW - Taiwan 5
AL - Albania 4
DK - Danimarca 4
KG - Kirghizistan 4
PT - Portogallo 4
SK - Slovacchia (Repubblica Slovacca) 4
SY - Repubblica araba siriana 4
AZ - Azerbaigian 3
BG - Bulgaria 3
CI - Costa d'Avorio 3
GT - Guatemala 3
IR - Iran 3
KR - Corea 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
NP - Nepal 3
OM - Oman 3
PS - Palestinian Territory 3
QA - Qatar 3
AO - Angola 2
BH - Bahrain 2
BS - Bahamas 2
CH - Svizzera 2
ET - Etiopia 2
GE - Georgia 2
HU - Ungheria 2
IE - Irlanda 2
LV - Lettonia 2
MD - Moldavia 2
MN - Mongolia 2
SR - Suriname 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CU - Cuba 1
EE - Estonia 1
EU - Europa 1
GI - Gibilterra 1
Totale 14.808
Salva come PNG Salva come JPEG
Città #
Ashburn 947
Singapore 908
Fairfield 708
Woodbridge 563
San Jose 530
Houston 488
Santa Clara 323
Council Bluffs 319
Beijing 303
Hong Kong 301
Chandler 286
Seattle 278
Warsaw 268
Jacksonville 267
Wilmington 247
Cambridge 237
Dallas 225
Ferrara 208
Ann Arbor 181
Ho Chi Minh City 151
Los Angeles 141
New York 118
Munich 113
Izmir 110
Hanoi 107
Nanjing 83
Tokyo 79
Princeton 72
Lauterbourg 64
San Diego 64
Boardman 59
Jakarta 57
Orem 54
Milan 48
Helsinki 47
Shanghai 40
São Paulo 39
London 38
Montreal 38
Chicago 36
Buffalo 34
Falls Church 33
Bologna 31
Mexico City 29
Chennai 28
Brooklyn 27
Frankfurt am Main 27
Toronto 26
Shenyang 25
Atlanta 23
Nanchang 23
The Dalles 23
Denver 22
Dong Ket 22
Johannesburg 22
Turku 22
Hefei 21
Manchester 21
Poplar 21
Dearborn 20
San Mateo 20
Da Nang 19
Rio de Janeiro 19
Tianjin 19
Amsterdam 18
Stockholm 18
Columbus 17
Haiphong 17
Jiaxing 17
Phoenix 17
Rome 17
Boston 16
Guangzhou 16
Mumbai 16
Changsha 15
Auburn Hills 14
Brussels 14
Hebei 14
Tashkent 14
Nuremberg 13
Ankara 12
Bremen 12
Falkenstein 12
Montréal 12
San Francisco 12
Baghdad 11
Bari 11
Dhaka 11
Mountain View 11
Ninh Bình 11
Norwalk 11
Curitiba 10
Elk Grove Village 10
Jinan 10
Kunming 10
Madrid 10
Moscow 10
Padua 10
Tappahannock 10
Zhengzhou 10
Totale 10.191
Salva come PNG Salva come JPEG
Nome #
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity 343
Targeting mTOR in Acute Lymphoblastic Leukemia 297
The anti-leukemic activity of sodium dichloroacetate in p53(mutated/null) cells is mediated by a p53-independent ILF3/p21 pathway 279
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 276
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 272
Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism 264
Crosstalk between adipokines and paraoxonase 1: A new potential axis linking oxidative stress and inflammation 264
Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells 258
Conjunctival sac fluid contains elevated levels of soluble TRAIL: implications for the anti-tumoral surveillance of the anterior surface of the eye 254
Characterization Methods for Nanoparticle–Skin Interactions: An Overview 233
Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-hodgkin's lymphoma xenografts 233
Differential gene expression induction by TRAIL in B chronic lymphocytic leukemia (B-CLL) cells showing high versus low levels of Zap-70 232
Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1 232
The MDM-2 antagonist nutlin-3 promotes the maturation of acute myeloid leukemic blasts 230
Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes 230
The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias 229
TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative Stress 228
Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets 220
Kinetic Profiles of Inflammatory Mediators in the Conjunctival Sac Fluid of Patients upon Photorefractive Keratectomy 218
Extracellular Tat activates c-fos promoter in low serum-starved CD4+ T cells 215
Eosinophils and purinergic signaling in health and disease 211
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status 209
The MDM2 inhibitor Nutlin-3 attenuates streptozotocin-induced diabetes mellitus and increases serum level of IL-12p40. 208
Combined treatment of CpG-oligodeoxynucleotide with Nutlin-3 induces strong immune stimulation coupled to cytotoxicity in B-chronic lymphocytic leukemic (B-CLL) cells 206
Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease 200
Release of a specific set of proinflammatory adipokines by differentiating 3T3-L1 cells 198
Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells 191
Potential role of PKC inhibitors in the treatment of hematological malignancies 186
Autoinflammatory diseases and cytokine storms-imbalances of innate and adaptative immunity 186
Genistein exerts in vitro anti-inflammatory effects via NLRP3 modulation in a keratinocyte model 184
Microfluidic Fabricated Liposomes for Nutlin-3a Ocular Delivery as Potential Candidate for Proliferative Vitreoretinal Diseases Treatment 183
Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells 183
Human skin volatilome: a pleiotropic tool to study inflammatory skin conditions 180
The gamma-secretase inhibitors enhance the anti-leukemic activity of ibrutinib in B-CLL cells 176
Role of full-length osteoprotegerin in tumor cell biology. 175
Role of CREB transcription factor in c-fos activation in natural killer cells. 174
Sorafenib inhibits in vitro osteoclastogenesis by down-modulating Mcl-1 172
C reactive protein down-regulates TNF-related apoptosis inducing ligand expression in human peripheral monocytes via an Egr-1 dependent pathway. 170
In vitro apoptotic cell death during erythroid differentiation 168
Colorectal cancer study with nanostructured sensors: Tumor marker screening of patient biopsies 168
Merkel-cell polyomavirus (MCPyV) is rarely associated to B-chronic lymphocytic leukemia (1 out of 50) samples and occurs late in the natural history of the disease 168
Baseline and overtime variations of soluble adhesion molecule plasma concentrations are associated with mobility recovery after rehabilitation in multiple sclerosis patients 164
Role of vitamin D in the pathogenesis of atheromatosis 163
Evaluation of Anticancer Activity of Nucleoside-Nitric Oxide Photo-Donor Hybrids 161
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets? 158
Supravital exposure to propidium iodide identifies apoptosis on adherent cells 156
The oncogene DEK promotes leukemic cell survival and is downregulated by both nutlin-3 and chlorambucil in B-chronic lymphocytic leukemic cells 155
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-α promote the NF-κB-dependent maturation of normal and leukemic myeloid cells 154
TRICALCIUM PHOSPHATE STIMULATES ADIPOSE TISSUE-DERIVED STEM CELLS TOWARDS OSTEOBLASTS DIFFERENTIATION 154
Human collecting lymphatic glycocalyx identification by electron microscopy and immunohistochemistry 150
SOCS1 is significantly up-regulated in Nutlin-3-treated p53 wild-type B chronic lymphocytic leukemia (BCLL) samples and shows an inverse correlation with miR-155 150
Convolvulus pluricaulis Choisy’s Extraction, Chemical Characterization and Evaluation of the Potential Effects on Glycaemic Balance in a 3T3-L1 Adipocyte Cell Model 145
MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib 144
The negative prognostic value of TRAIL overexpression in oral squamous cell carcinomas does not preclude the potential therapeutic use of recombinant TRAIL. 143
Selection and characterization of a novel agonistic human recombinant anti-Trail-R2 minibody with anti-leukemic activity 142
Acute Neurological Involvement after Donor Lymphocyte Infusion for Post-Transplant Viral Infection: The Same Pattern of Novel Cancer Immunotherapy-Related CNS Toxicity? 141
Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside. 140
TRAIL regulates normal erythroid maturation through an ERK-dependent pathway 138
Synthesis and Biological Investigation of Bile Acid-Paclitaxel Hybrids 136
Decreased levels of soluble TNF-related apoptosis-inducing ligand (TRAIL) in the conjunctival sac fluid of patients with diabetes affected by proliferative retinopathy. 133
Role of miRNA in adult ocular tumorigenesis 131
Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors 126
Prenylation Defects and Oxidative Stress Trigger the Main Consequences of Neuroinflammation Linked to Mevalonate Pathway Deregulation 124
The expression levels of the pro-apoptotic XAF-1 gene modulate the cytotoxic response to Nutlin-3 in B chronic lymphocytic leukemia 121
The response of human natural killer cells to interleukin-2. 120
Dasatinib plus Nutlin-3 shows synergistic anti-leukemic activity in both p53wild-type and p53mutated B chronic lymphocytic leukemias by inhibiting the Akt pathway. 117
Palmitic Acid Induced a Long-Lasting Lipotoxic Insult in Human Retinal Pigment Epithelial Cells, which Is Partially Counteracted by TRAIL 116
TNFSF10 (tumor necrosis factor Ligand) surfamily,member 10) 114
miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells. 113
Mevalonate Kinase Deficiency and Squalene Synthase Inhibitor (TAK-475): The Balance to Extinguish the Inflammation 111
Functional expression of TRAIL and TRAIL-R2 during human megakaryocytic development 106
MitoQ is able to modulate apoptosis and inflammation 105
TNF-related apoptosis-inducing ligand (TRAIL) up-regulates cyclooxygenase (COX)-1 activity and PGE(2) production in cells of the myeloid lineage 104
New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib 98
null 96
null 92
Trained Immunity and Its Potential Implications in the Etiopathogenesis of Hidradenitis Suppurativa: A New Paradigm in Chronic Inflammation? 90
null 90
Perifosine plus nutlin-3 combination shows a synergistic anti-leukaemic activity. 90
null 89
Tumor necrosis factor-related apoptosis-inducing ligand induces monocytic maturation of leukemic and normal myeloid precursors through a caspase-dependent pathway 89
null 88
null 84
null 83
null 76
null 76
PEPTIDE-15 STIMULATES PULP STEM CELLS TOWARDS OSTEOBLASTS DIFFERENTIATION 71
null 69
Biological Evaluation and SAR Exploration of Bile Acid-Dihydroartemisinin Hybrids as Potential Anticancer Agents for Colorectal Cancer 68
Phytocompounds in Precision Dermatology: COX-2 Inhibitors as a Therapeutic Target in Atopic-Prone Skin 65
TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF 62
Inverse correlation between circulating levels of TNF-related apoptosis-inducing ligand and 17β-estradiol 56
null 45
Towards defining the chemical signature of inflammatory skin conditions: an in vitro model 38
TOWARDS DEFINING THE CHEMICAL SIGNATURE OF INFLAMMATORY SKIN CONDITIONS USING VOLATILE METABOLITES: AN IN VITRO MODEL 37
Targeting Intestinal Permeability for Graft-versus-Host Disease Treatment: A Therapeutic Perspective with Defibrotide 35
Biological evaluation of dihydroartemisinin-hybrids as potential anticancer agents for colon carcinoma 31
Liposome-loaded Nutlin-3a as a potential candidate for the treatment of proliferative vitreoretinal diseases 26
null 15
Exploratory Volatilome Profiling of Inflammation in Skin Fibroblasts: A Proof-of-Concept Study 14
Totale 15.011
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.735
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.735
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022740 0 66 50 16 64 51 67 39 28 74 82 203
2022/2023716 83 38 31 78 102 109 39 56 90 7 47 36
2023/2024391 55 32 10 8 28 59 15 40 2 10 16 116
2024/20251.813 46 36 148 87 249 134 71 106 327 170 247 192
2025/20266.123 570 325 488 705 815 374 707 362 645 719 241 172
2026/2027478 165 313 0 0 0 0 0 0 0 0 0 0
Totale 15.015